Prognosis
AstraZeneca-Oxford Covid Vaccine Gains First Clearance With U.K. Nod
- Vaccinations to start in new year as cases rise across Britain
- Recipients to get second shot within 12 weeks of first one
This article is for subscribers only.
AstraZeneca Plc and the University of Oxford’s Covid-19 vaccine won U.K. clearance, marking the first approval worldwide for a shot that will be key to mass immunizations despite continuing questions over its efficacy.
The vaccine will be prioritized for the country’s most vulnerable groups, with shots starting Monday, according to the government. It’s the second coronavirus injection to be cleared for emergency use in the U.K., after one from Pfizer Inc. and BioNTech SE was authorized in early December.